Skip to main content
Clinical Trials/NCT00115479
NCT00115479
Completed
Phase 2

KULeuven Intensive Insulin Therapy Study in Medical Intensive Care Patients

KU Leuven1 site in 1 country1,200 target enrollmentMarch 2002

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Critical Illness
Sponsor
KU Leuven
Enrollment
1200
Locations
1
Primary Endpoint
mortality
Status
Completed
Last Updated
20 years ago

Overview

Brief Summary

In a previous study, we showed that tight blood glucose control with insulin during intensive care reduced morbidity and mortality of surgical intensive care patients. Whether this intervention also improves prognosis of medical intensive care patients remains unknown. The current prospective, randomized, controlled study will assess the impact of intensive insulin therapy on the outcome of patients in a medical intensive care unit. On admission, patients will be randomly assigned to either strict normalization of blood glucose (80-110 mg/dl) with intensive insulin therapy or the conventional approach, in which insulin infusion is initiated only when blood glucose exceeds 215 mg/dl, to maintain blood glucose levels between 180 and 200 mg/dl.

Detailed Description

In a previous study, we showed that tight blood glucose control with insulin during intensive care reduced morbidity and mortality of surgical intensive care patients. Whether this intervention also improves prognosis of medical intensive care patients remains unknown. The current prospective, randomized, controlled study will assess the impact of intensive insulin therapy on the outcome of patients in a medical intensive care unit. On admission, patients will be randomly assigned to either strict normalization of blood glucose (80-110 mg/dl) with intensive insulin therapy or the conventional approach, in which insulin infusion is initiated only when blood glucose exceeds 215 mg/dl, to maintain blood glucose levels between 180 and 200 mg/dl.

Registry
clinicaltrials.gov
Start Date
March 2002
End Date
June 2005
Last Updated
20 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
KU Leuven

Eligibility Criteria

Inclusion Criteria

  • Adults admitted to ICU and anticipated to require intensive care for at least a few days

Exclusion Criteria

  • Expected short ICU stay
  • Therapy restricted upon admission
  • Surgical ICU patients
  • Other studies
  • Below 18 years
  • Pregnancy

Outcomes

Primary Outcomes

mortality

Secondary Outcomes

  • mechanical ventilatory support-dependency
  • stay in Intensive Care Unit (ICU)
  • stay in hospital
  • organ failure
  • morbidity
  • a long-term follow up is planned to take place 6 and 12 months after hospital discharge

Study Sites (1)

Loading locations...

Similar Trials